AN2 Therapeutics, Inc. Insider Transactions
AN2 Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Readnour Robin Shane
Director |
Buy | 5,000 @ $1.49 | $7,462 | 582,288 | 12/10/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 12,289 @ $1.43 | $17,577 | 577,288 | 12/09/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 18,483 @ $1.43 | $26,407 | 647,573 | 12/09/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 12,711 @ $1.45 | $18,367 | 564,999 | 12/06/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 6,517 @ $1.45 | $9,427 | 629,090 | 12/06/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 25,000 @ $1.42 | $35,423 | 552,288 | 11/27/2024 | 11/27/2024 | |
|
Zakrzewski Joseph S
Director |
Buy | 2,000 @ $1.40 | $2,800 | 125,199 | 11/27/2024 | 11/27/2024 | |
|
Readnour Robin Shane
Director |
Buy | 12,500 @ $1.39 | $17,418 | 527,288 | 11/26/2024 | 11/27/2024 | |
|
Readnour Robin Shane
Director |
Buy | 25,000 @ $1.15 | $28,870 | 514,788 | 11/20/2024 | 11/21/2024 | |
|
Readnour Robin Shane
Director |
Buy | 75,000 @ $1.04 | $77,730 | 489,788 | 11/19/2024 | 11/21/2024 | |
|
Zakrzewski Joseph S
Director |
Buy | 5,000 @ $1.01 | $5,050 | 123,199 | 11/19/2024 | 11/20/2024 | |
|
Zakrzewski Joseph S
Director |
Buy | 20,000 @ $1.00 | $19,996 | 118,199 | 11/18/2024 | 11/20/2024 | |
|
Easom Eric
CEO |
Buy | 50,000 @ $1.00 | $49,970 | 1,065,766 | 11/18/2024 | 11/18/2024 | |
|
Leonard Braden Michael
10 percent owner |
Buy | 1,500,000 @ $1.04 | $1.56 M | 5,749,432 | 08/14/2024 | 08/14/2024 | |
|
RA CAPITAL MANAGEMENT, L.P.
10 percent owner |
Sell | 3,410,335 @ $1.08 | $3.68 M | 1,725,348 | 08/09/2024 | 08/13/2024 | |
|
RA CAPITAL MANAGEMENT, L.P.
10 percent owner |
Sell | 114,759 @ $1.08 | $123,940 | 300,853 | 08/09/2024 | 08/13/2024 | |
|
Zakrzewski Joseph S
Director |
Sell | 100,000 @ $19.11 | $1.91 M | 405,880 | 01/18/2024 | 01/19/2024 | |
|
Aziz Kabeer
Director |
Sell | 84,093 @ $19.65 | $1.65 M | 1,995,958 | 01/16/2024 | 01/18/2024 | |
|
Adjuvant Global Health Technology Fund, L.P.
10 percent owner |
Sell | 84,093 @ $19.65 | $1.65 M | 1,995,958 | 01/16/2024 | 01/18/2024 | |
|
Adjuvant Global Health Technology Fund, L.P.
10 percent owner |
Sell | 15,907 @ $19.65 | $312,573 | 377,542 | 01/16/2024 | 01/18/2024 |
AN2 Therapeutics, Inc. FAQ's
Who is on AN2 Therapeutics, Inc.'s Insider Roster?
The list of insiders at AN2 Therapeutics, Inc. includes Aziz Kabeer, Adjuvant Global Health Technology Fund, L.P., Zakrzewski Joseph S, RA CAPITAL MANAGEMENT, L.P., Leonard Braden Michael, Easom Eric, Readnour Robin Shane.
How much insider selling is happening at AN2 Therapeutics, Inc.?
Insiders have sold a total of 3.83 M AN2 Therapeutics, Inc. shares in the last 12 months for a total of 9.65 M sold.
Which AN2 Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold AN2 Therapeutics, Inc. shares in the last 12 months: Aziz Kabeer ($1.97 M), Adjuvant Global Health Technology Fund, L.P. ($1.97 M), Zakrzewski Joseph S ($1.91 M), RA CAPITAL MANAGEMENT, L.P. ($3.81 M),
How much insider buying is happening at AN2 Therapeutics, Inc.?
Insiders have purchased a total of 1.77 M AN2 Therapeutics, Inc. shares in the last 12 months for a total of 1.88 M.
Which AN2 Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased AN2 Therapeutics, Inc. shares in the last 12 months: Leonard Braden Michael ($1.56 M), Zakrzewski Joseph S ($27,846), Easom Eric ($49,970), Readnour Robin Shane ($238,681),